Whole-genome sequencing-based epidemiological analysis of anti-tuberculosis drug resistance genes in Japan in 2007: Application of the Genome Research for Asian Tuberculosis (GReAT) database
- PMID: 31492902
- PMCID: PMC6731343
- DOI: 10.1038/s41598-019-49219-5
Whole-genome sequencing-based epidemiological analysis of anti-tuberculosis drug resistance genes in Japan in 2007: Application of the Genome Research for Asian Tuberculosis (GReAT) database
Abstract
We investigated the lineages of Mycobacterium tuberculosis (Mtb) isolates from the RYOKEN study in Japan in 2007 and the usefulness of genotypic drug susceptibility testing (DST) using the Genome Research for Asian Tuberculosis (GReAT) database. In total, 667 isolates were classified into lineage 1 (4.6%), lineage 2 (0.8%), lineage 2/Beijing (72.1%), lineage 3 (0.5%), and lineage 4 (22.0%). The nationality, gender, and age groups associated with the isolates assigned to lineage 1 were significantly different from those associated with other lineages. In particular, isolates of lineage 1.2.1 (EAI2) formed sub-clusters and included a 2,316-bp deletion in the genome. The proportion of the isolates resistant to at least one anti-tuberculosis (TB) drug was 10.8%, as determined by either the genotypic or phenotypic method of DST. However, the sensitivities to isoniazid, streptomycin, and ethambutol determined by the genotypic method were low. Thus, unidentified mutations in the genome responsible for drug resistance were explored, revealing previously unreported mutations in the katG, gid, and embB genes. This is the first nationwide report of whole-genome analysis of TB in Japan.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.J Glob Antimicrob Resist. 2019 Mar;16:170-177. doi: 10.1016/j.jgar.2018.08.018. Epub 2018 Aug 29. J Glob Antimicrob Resist. 2019. PMID: 30172045
-
Diversified lineages and drug-resistance profiles of clinical isolates of Mycobacterium tuberculosis complex in Malaysia.Int J Mycobacteriol. 2019 Oct-Dec;8(4):320-328. doi: 10.4103/ijmy.ijmy_144_19. Int J Mycobacteriol. 2019. PMID: 31793500
-
Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.J Glob Antimicrob Resist. 2018 Dec;15:239-245. doi: 10.1016/j.jgar.2018.08.009. Epub 2018 Aug 18. J Glob Antimicrob Resist. 2018. PMID: 30130640
-
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42. doi: 10.5588/ijtld.15.0221. Int J Tuberc Lung Dis. 2016. PMID: 26688526 Review.
-
Systematic Review of Whole-Genome Sequencing Data To Predict Phenotypic Drug Resistance and Susceptibility in Swedish Mycobacterium tuberculosis Isolates, 2016 to 2018.Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02550-19. doi: 10.1128/AAC.02550-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32122893 Free PMC article.
Cited by
-
Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis.DNA Res. 2024 Aug 1;31(4):dsae023. doi: 10.1093/dnares/dsae023. DNA Res. 2024. PMID: 39127874 Free PMC article.
-
Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance.Epidemiol Infect. 2022 Jan 7;150:e22. doi: 10.1017/S095026882100279X. Epidemiol Infect. 2022. PMID: 35086603 Free PMC article.
-
New insight in molecular detection of Mycobacterium tuberculosis.AMB Express. 2024 Jun 21;14(1):74. doi: 10.1186/s13568-024-01730-3. AMB Express. 2024. PMID: 38907086 Free PMC article. Review.
-
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.BMC Genomics. 2024 Nov 1;25(1):1024. doi: 10.1186/s12864-024-10909-8. BMC Genomics. 2024. PMID: 39487429 Free PMC article.
-
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.Sci Rep. 2023 Feb 13;13(1):2540. doi: 10.1038/s41598-023-29652-3. Sci Rep. 2023. PMID: 36781938 Free PMC article.
References
-
- Reechaipichitkul, W., Tubtim, S. & Chaimanee, P. Drug susceptibility patterns of Mycobacterium tuberculosis and clinical outcomes of drug-resistant tuberculosis at Srinagarind Hospital, a tertiary care center in northeastern Thailand. The Southeast Asian journal of tropical medicine and public health. 42(5), 1154–62 (2011 Sep). - PubMed
-
- Elmi Omar Sald, Hasan Habsah, Abdullah Sarimah, Mat Jeab Mat Zuki, Bin Alwi Zilfalil, Naing Nyi Nyi. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. The Journal of Infection in Developing Countries. 2015;9(10):1076–1085. doi: 10.3855/jidc.6162. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources